4.8 Review

Advanced Nanomaterials for Preparedness Against (Re-)Emerging Viral Diseases

期刊

ADVANCED MATERIALS
卷 33, 期 47, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202005927

关键词

antiviral therapeutics; diagnostic tools; emerging viral diseases; nanomaterials; nanovaccines

资金

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT) [2020R1F1A1066247]
  2. Basic Science Research Program of the NRF - MSIT [NRF2018R1C1B6005424]
  3. Center for BioNano Health Guard - Ministry of Science and ICT (MSIT) [2014M3A6B2060507]
  4. KRIBB Research Initiative Program
  5. Korea Mouse Phenotyping Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2019M3A9D5A01102797]
  6. Bio & Medical Technology Development Programs of the NRF - MSIT [NRF-2018M3A9H4056340, NRF-2018M3A9E2022819]
  7. Nano Material Technology Development Program through the NRF - Ministry of Education, Science and Technology [2017M3A7B4041798]
  8. National Research Council of Science & Technology (NST), Republic of Korea [KGM5472113, KGM1012112] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
  9. National Research Foundation of Korea [2018M3A9H4056340, 2018M3A9E2022819, 2020R1F1A1066247] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

While COVID-19 is currently causing a global pandemic, the emergence of unknown pathogens such as Disease X is a serious concern for the future. Utilizing advanced nanotechnology to address the challenges posed by emerging pathogens is crucial for global public health preparedness.
While the coronavirus disease (COVID-19) accounts for the current global pandemic, the emergence of other unknown pathogens, named Disease X, remains a serious concern in the future. Emerging or re-emerging pathogens continue to pose significant challenges to global public health. In response, the scientific community has been urged to create advanced platform technologies to meet the ever-increasing needs presented by these devastating diseases with pandemic potential. This review aims to bring new insights to allow for the application of advanced nanomaterials in future diagnostics, vaccines, and antiviral therapies, thereby addressing the challenges associated with the current preparedness strategies in clinical settings against viruses. The application of nanomaterials has advanced medicine and provided cutting-edge solutions for unmet needs. Herein, an overview of the currently available nanotechnologies is presented, highlighting the significant features that enable them to control infectious diseases, and identifying the challenges that remain to be addressed for the commercial production of nano-based products is presented. Finally, to conclude, the development of a nanomaterial-based system using a One Health approach is suggested. This strategy would require a transdisciplinary collaboration and communication between all stakeholders throughout the entire process spanning across research and development, as well as the preclinical, clinical, and manufacturing phases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据